IBDEI0UR ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,13697,1,4,0)
 ;;=4^E11.3213
 ;;^UTILITY(U,$J,358.3,13697,2)
 ;;=^5138333
 ;;^UTILITY(U,$J,358.3,13698,0)
 ;;=E11.3291^^83^815^26
 ;;^UTILITY(U,$J,358.3,13698,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13698,1,3,0)
 ;;=3^Diabetes Type 2 w/ Mild Nonp Rtnop w/o Macular Edema,Right Eye
 ;;^UTILITY(U,$J,358.3,13698,1,4,0)
 ;;=4^E11.3291
 ;;^UTILITY(U,$J,358.3,13698,2)
 ;;=^5138335
 ;;^UTILITY(U,$J,358.3,13699,0)
 ;;=E11.3292^^83^815^27
 ;;^UTILITY(U,$J,358.3,13699,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13699,1,3,0)
 ;;=3^Diabetes Type 2 w/ Mild Nonp Rtnop w/o Macular Edema,Left Eye
 ;;^UTILITY(U,$J,358.3,13699,1,4,0)
 ;;=4^E11.3292
 ;;^UTILITY(U,$J,358.3,13699,2)
 ;;=^5138336
 ;;^UTILITY(U,$J,358.3,13700,0)
 ;;=E11.3293^^83^815^28
 ;;^UTILITY(U,$J,358.3,13700,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13700,1,3,0)
 ;;=3^Diabetes Type 2 w/ Mild Nonp Rtnop w/o Macular Edema,Bilateral
 ;;^UTILITY(U,$J,358.3,13700,1,4,0)
 ;;=4^E11.3293
 ;;^UTILITY(U,$J,358.3,13700,2)
 ;;=^5138337
 ;;^UTILITY(U,$J,358.3,13701,0)
 ;;=E11.3311^^83^815^29
 ;;^UTILITY(U,$J,358.3,13701,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13701,1,3,0)
 ;;=3^Diabetes Type 2 w/ Mod Nonp Rtnop w/ Macular Edema,Right Eye
 ;;^UTILITY(U,$J,358.3,13701,1,4,0)
 ;;=4^E11.3311
 ;;^UTILITY(U,$J,358.3,13701,2)
 ;;=^5138339
 ;;^UTILITY(U,$J,358.3,13702,0)
 ;;=E11.3312^^83^815^30
 ;;^UTILITY(U,$J,358.3,13702,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13702,1,3,0)
 ;;=3^Diabetes Type 2 w/ Mod Nonp Rtnop w/ Macular Edema,Left Eye
 ;;^UTILITY(U,$J,358.3,13702,1,4,0)
 ;;=4^E11.3312
 ;;^UTILITY(U,$J,358.3,13702,2)
 ;;=^5138340
 ;;^UTILITY(U,$J,358.3,13703,0)
 ;;=E11.3313^^83^815^31
 ;;^UTILITY(U,$J,358.3,13703,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13703,1,3,0)
 ;;=3^Diabetes Type 2 w/ Mod Nonp Rtnop w/ Macular Edema,Bilateral
 ;;^UTILITY(U,$J,358.3,13703,1,4,0)
 ;;=4^E11.3313
 ;;^UTILITY(U,$J,358.3,13703,2)
 ;;=^5138341
 ;;^UTILITY(U,$J,358.3,13704,0)
 ;;=E11.3391^^83^815^32
 ;;^UTILITY(U,$J,358.3,13704,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13704,1,3,0)
 ;;=3^Diabetes Type 2 w/ Mod Nonp Rtnop w/o Macular Edema,Right Eye
 ;;^UTILITY(U,$J,358.3,13704,1,4,0)
 ;;=4^E11.3391
 ;;^UTILITY(U,$J,358.3,13704,2)
 ;;=^5138343
 ;;^UTILITY(U,$J,358.3,13705,0)
 ;;=E11.3392^^83^815^33
 ;;^UTILITY(U,$J,358.3,13705,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13705,1,3,0)
 ;;=3^Diabetes Type 2 w/ Mod Nonp Rtnop w/o Macular Edema,Left Eye
 ;;^UTILITY(U,$J,358.3,13705,1,4,0)
 ;;=4^E11.3392
 ;;^UTILITY(U,$J,358.3,13705,2)
 ;;=^5138344
 ;;^UTILITY(U,$J,358.3,13706,0)
 ;;=E11.3393^^83^815^34
 ;;^UTILITY(U,$J,358.3,13706,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13706,1,3,0)
 ;;=3^Diabetes Type 2 w/ Mod Nonp Rtnop w/o Macular Edema,Bilateral
 ;;^UTILITY(U,$J,358.3,13706,1,4,0)
 ;;=4^E11.3393
 ;;^UTILITY(U,$J,358.3,13706,2)
 ;;=^5138345
 ;;^UTILITY(U,$J,358.3,13707,0)
 ;;=E11.3411^^83^815^43
 ;;^UTILITY(U,$J,358.3,13707,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13707,1,3,0)
 ;;=3^Diabetes Type 2 w/ Severe Nonp Rtnop w/ Macular Edema,Right Eye
 ;;^UTILITY(U,$J,358.3,13707,1,4,0)
 ;;=4^E11.3411
 ;;^UTILITY(U,$J,358.3,13707,2)
 ;;=^5138347
 ;;^UTILITY(U,$J,358.3,13708,0)
 ;;=E11.3412^^83^815^44
 ;;^UTILITY(U,$J,358.3,13708,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13708,1,3,0)
 ;;=3^Diabetes Type 2 w/ Severe Nonp Rtnop w/ Macular Edema,Left Eye
